SCHEMBL7478697

SCHEMBL7478697

CCCCCOc1nc(CC)c(-c2c(C)cc(C)cc2OC)nc1CC

nearest known ligand 0.49

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CRHR1 P34998 19/20 0.49
CNR2 P34972 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7474131 0.84 CNR2 (0.38) CRHR1CNR2
SCHEMBL7475280 0.80 MCHR1 (0.39) CRHR1
SCHEMBL5409624 0.80 CRHR1 (0.55) CRHR1
SCHEMBL6202588 0.79 CRHR1 (0.38) CRHR1
SCHEMBL7474497 0.79 MCHR1 (0.40)
SCHEMBL5414915 0.79 CRHR1 (0.47) CRHR1
SCHEMBL5409765 0.78 CRHR1 (0.48) CRHR1
SCHEMBL7473334 0.77 CRHR1 (0.45) CRHR1CNR2
SCHEMBL7477213 0.76 CRHR1 (0.39) CRHR1
SCHEMBL6201091 0.74 CRHR1 (0.43) CRHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1255740-A2 SUBSTITUTED ARYLPYRAZINES NEUROGEN CORPORATION (US) 2002-11-13 EP claimed
WO-2001060806-A2 SUBSTITUTED ARYLPYRAZINES NEUROGEN CORPORATION (US) 2001-08-23 WO claimed